Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Updated Follow-up of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (SB-525) Gene Therapy in Adults with Severe Hemophilia a

Andrew D. Leavitt, MD, Barbara A. Konkle, MD, Kimo Stine, MD, Nathan Visweshwar, MD, Thomas J. Harrington, MD, Adam Giermasz, MD PhD, Steven Arkin, MD, Annie Fang, MD PhD, Frank Plonski, RN, MA, Lynne Smith, MBA, Li-Jung Tseng, PhD MBA, Gregory Di Russo, MD, Bettina M Cockroft, MD, Jeremy Rupon, MD, Didier Rouy, MD PhD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-137648

Published: 2020

Journal Articles

Updated Follow-up of the Alta Study, a Phase 1/2, Open Label, Adaptive, Dose-Ranging Study to Assess the Safety and Tolerability of SB-525 Gene Therapy in Adult Patients with Severe Hemophilia A

Barbara A. Konkle, MD, Kimo Stine, MD, Nathan Visweshwar, MD, Thomas J. Harrington, MD, Andrew D. Leavitt, MD, Adam Giermasz, MD PhD, Steven Arkin, MD, Gregory Di Russo, MD, Ashley Snyder, PharmD, MPH, Adrian Woolfson, MD PhD, Didier Rouy, MD PhD

Blood (2019) 134 (Supplement_1): 2060.

https://doi.org/10.1182/blood-2019-122143

Published: 2019

Journal Articles

101HEMB01 Is a Phase 1/2 Open-Label, Single Ascending Dose-Finding Trial of DTX101 (AAVrh10FIX) in Patients with Moderate/Severe Hemophilia B That Demonstrated Meaningful but Transient Expression of Human Factor IX (hFIX)

Steven Pipe, MD, Kimo Stine, MD, Anita Rajasekhar, MD, Tamara Everington, MD, Allen Poma, MD, Eric Crombez, MD, Charles RM Hay, MD

Blood (2017) 130 (Supplement 1): 3331.

https://doi.org/10.1182/blood.V130.Suppl_1.3331.3331

Published: 2017

Journal Articles

A Pilot Study To Examine The Effect Of Extracorporeal Membrane Oxygenation (ECMO) On Plasma Factor XIII Levels

Dimarys Sanchez, MD, Kimo Stine, MD, Shelley E. Crary, MD, MSCS, Richard Fiser, MD, Michael Schmitz, MD, Parthak Prodham, MD, Todd Nick, PhD, Xinyu Tang, PhD

Blood (2013) 122 (21): 4774.

https://doi.org/10.1182/blood.V122.21.4774.4774

Published: 2013

Journal Articles

The North American Chronic Immune Thrombocytopenia Registry (NACIR): Demographics and Treatment Responses

Rachael F. Grace, MD, Ellis J. Neufeld, MD, PhD, A. Kim Ritchey, MD, Manjusha Kumar, MD, Michael R. Jeng, MD, Victor Blanchette, MD, Robert Klaassen, MD, FRCP, George R. Buchanan, MD, Margaret A. Heisel Kurth, MD, Diane J. Nugent, MD, Alexis A. Thompson, MD, MPH, Courtney Thornburg, MD, MS, Michele P. Lambert, MD, Michelle D. Neier, MD, Michael Recht, MD, PhD, Kimo Stine, MD, Leslie A. Kalish, ScD, Carolyn M. Bennett, MD, MS

Blood (2010) 116 (21): 2509.

https://doi.org/10.1182/blood.V116.21.2509.2509

Published: 2010

Journal Articles

Response to Steroids Predicts Response to Rituximab In Pediatric Chronic Immune Thrombocytopenia.

Rachael F. Grace, MD, Carolyn M. Bennett, MD, MS, A. Kim Ritchey, MD, Michael R. Jeng, MD, Courtney Thornburg, MD, MS, Michele Lambert, MD, Michelle Neier, MD, Michael Recht, MD, PhD, Manjusha Kumar, MD, Victor Blanchette, MD, Robert Klaassen, MD, FRCP, George R. Buchanan, MD, Margaret A. Heisel Kurth, MD, Diane J. Nugent, MD, Alexis A. Thompson, MD, MPH, Kimo Stine, MD, Leslie A. Kalish, ScD, Ellis J. Neufeld, MD, PhD

Blood (2010) 116 (21): 3681.

https://doi.org/10.1182/blood.V116.21.3681.3681

Published: 2010

Journal Articles

C-Reactive Protein and Soluble IL-2Receptor Correlate with High Risk of Clinical Sepsis Among Children with Fever and Neutropenia.

Amir Mian, MD, MS, David Becton, MD, Richard Fiser, MD, Laura James, MD, Suzanne Saccente, MD, Robert Saylors, MD, Kimo Stine, MD, Maria Melguizo, MS

Blood (2009) 114 (22): 1406.

https://doi.org/10.1182/blood.V114.22.1406.1406

Published: 2009

Journal Articles

Effects of Angiotensin-Converting Enzyme Inhibition on Thromboelastogaphy for Infants and Children Presenting for Elective Cardiac Surgery.

Michael L Schmitz, MD, Edgar D St. Amour, M.Sc., Kimo Stine, MD, Mark A Austen, MS, Chanhee Jo, PhD, Pamela Killebrew, RNP, Robert J Jaquiss, MD

Blood (2008) 112 (11): 1225.

https://doi.org/10.1182/blood.V112.11.1225.1225

Published: 2008

Journal Articles

Excessive Cardiotoxicity Despite Excellent Leukemia-Free Survival for Pediatric Patients with Down Syndrome (DS) and Acute Myeloid Leukemia (AML): Results from POG (Pediatric Oncology Group) Protocol 9421.

Maureen O’Brien, MD, Jeffrey Taub, MD, Kimo Stine, MD, Myron Chang, Yaddanapudi Ravindranath, MD, David Becton, MD, Gary Van Houten Dahl, MD

Blood (2006) 108 (11): 559.

https://doi.org/10.1182/blood.V108.11.559.559

Published: 2006

Journal Articles

TBI and Allogeneic BMT Do Not Appear To Hinder Growth in Pediatirc Patients with AML Treated on POG 9421 (Now Children’s Oncology Group).

Kimo Stine, MD, David Becton, MD, Gary Van Houten Dahl, MD, Yaddanapudi Ravindranath, MD, Susana C. Raimondi, PhD, Fred Behm, MD, Myron Chang, Robert Arceci, MD

Blood (2006) 108 (11): 3677.

https://doi.org/10.1182/blood.V108.11.3677.3677

Published: 2006

Journal Articles

Minor Surgical Procedures - Survey of Hematologists To Determine Preferences Regarding Management of Hemophilia Patients.

Kapil Saxena, MD, Sumbal Nabi, MD, Sara K. Vesely, PhD, Kalpana Pethe, MD, Sarah M. Hawk, PA-C, Kristina Johnson, Kimo Stine, MD

Blood (2006) 108 (11): 4067.

https://doi.org/10.1182/blood.V108.11.4067.4067

Published: 2006

Journal Articles

Major Surgical Interventions - Survey of Hematologists To Determine Personal/Institutional Preferences Regarding Management of Hemophilia Patients.

Kapil Saxena, MD, Sara K. Vesely, PhD, Sumbal Nabi, MD, Kalpana Pethe, MD, Sarah M. Hawk, PA-C, Kristina Johnson, Kimo Stine, MD

Blood (2006) 108 (11): 4068.

https://doi.org/10.1182/blood.V108.11.4068.4068

Published: 2006

Journal Articles

Quantitative Assessment of Drug Treatment Side Effects in Children with Idiopathic Thrombocytopenic Purpura (ITP).

George Buchanan, MD, Leah Adix, BS, Robert Klaassen, MD, Ellis Neufeld, MD, Ph.D., Sherri Zimmerman, MD, Kimo Stine, MD

Blood (2004) 104 (11): 3030.

https://doi.org/10.1182/blood.V104.11.3030.3030

Published: 2004

Journal Articles

Treatment of Deep Vein Thrombosis with Enoxaparin in Pediatric Cancer Patients Receiving Chemotherapy.

Kimo Stine, MD, Robert Saylors, MD, Suzanne Saccente, MD, David Becton, MD

Blood (2004) 104 (11): 4065.

https://doi.org/10.1182/blood.V104.11.4065.4065

Published: 2004

Journal Articles

Genetic Randomization to Allogeneic Bone Marrow Transplant in First Remission Pediatric Acute Myeloid Leukemia Patients, Pediatric Oncology Group 9421 (Now Childrens Oncology Group).

Kimo Stine, MD, David Becton, MD, Gary Van Houten Dahl, MD, Yaddanapudi Ravindranath, MD, Susana C. Raimondi, PhD, Fred G. Behm, MD, Myron Chang, PhD, Howard Weinstein, MD

Blood (2004) 104 (11): 616.

https://doi.org/10.1182/blood.V104.11.616.616

Published: 2004

NARROW

Updated Follow-up of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (SB-525) Gene Therapy in Adults with Severe Hemophilia a

Updated Follow-up of the Alta Study, a Phase 1/2, Open Label, Adaptive, Dose-Ranging Study to Assess the Safety and Tolerability of SB-525 Gene Therapy in Adult Patients with Severe Hemophilia A

101HEMB01 Is a Phase 1/2 Open-Label, Single Ascending Dose-Finding Trial of DTX101 (AAVrh10FIX) in Patients with Moderate/Severe Hemophilia B That Demonstrated Meaningful but Transient Expression of Human Factor IX (hFIX)

A Pilot Study To Examine The Effect Of Extracorporeal Membrane Oxygenation (ECMO) On Plasma Factor XIII Levels

The North American Chronic Immune Thrombocytopenia Registry (NACIR): Demographics and Treatment Responses

Response to Steroids Predicts Response to Rituximab In Pediatric Chronic Immune Thrombocytopenia.

C-Reactive Protein and Soluble IL-2Receptor Correlate with High Risk of Clinical Sepsis Among Children with Fever and Neutropenia.

Effects of Angiotensin-Converting Enzyme Inhibition on Thromboelastogaphy for Infants and Children Presenting for Elective Cardiac Surgery.

Excessive Cardiotoxicity Despite Excellent Leukemia-Free Survival for Pediatric Patients with Down Syndrome (DS) and Acute Myeloid Leukemia (AML): Results from POG (Pediatric Oncology Group) Protocol 9421.

TBI and Allogeneic BMT Do Not Appear To Hinder Growth in Pediatirc Patients with AML Treated on POG 9421 (Now Children’s Oncology Group).

Minor Surgical Procedures - Survey of Hematologists To Determine Preferences Regarding Management of Hemophilia Patients.

Major Surgical Interventions - Survey of Hematologists To Determine Personal/Institutional Preferences Regarding Management of Hemophilia Patients.

Quantitative Assessment of Drug Treatment Side Effects in Children with Idiopathic Thrombocytopenic Purpura (ITP).

Treatment of Deep Vein Thrombosis with Enoxaparin in Pediatric Cancer Patients Receiving Chemotherapy.

Genetic Randomization to Allogeneic Bone Marrow Transplant in First Remission Pediatric Acute Myeloid Leukemia Patients, Pediatric Oncology Group 9421 (Now Childrens Oncology Group).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only